Bioxcel therapeutics to report first quarter 2024 financial results on may 9, 2024

New haven, conn., april 25, 2024 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will release its first quarter 2024 financial results on thursday, may 9, 2024, before the open of the u.s. financial markets. bioxcel therapeutics' management team will also host a conference call and webcast at 8:00 am et that day to discuss the company's financial results and provide a general business update.
BTAI Ratings Summary
BTAI Quant Ranking